Clinical Trial Detail

NCT ID NCT02085408
Title Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Eastern Cooperative Oncology Group
Indications

acute myeloid leukemia

Therapies

Clofarabine

Cytarabine + Daunorubicin

Age Groups: adult senior

No variant requirements are available.